AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Columns of the U.S. Supreme Court at top of steps

8 wins for doctors, patients in latest federal budget deal

| 4 Min Read
Wooden blocks and figures accompany an up arrow

Do physicians need to switch jobs to climb the career ladder?

| 5 Min Read
Physician walking down a hallway

Women physicians face heavier burdens and higher burnout risk

| 9 Min Read
Adhesive bandage applied to upper arm of smiling young patient

Pediatric vaccines: Questions parents will ask—and how to answer

| 8 Min Read